Restricted accessResearch articleFirst published online 2012-02
Multi-Level Factorial Analysis of Ca 2+ /P i Supplementation as Bio-Instructive Media for In Vitro Biomimetic Engineering of Three-Dimensional Osteogenic Hybrids
We report on the in vitro use of Ca2+/Pi supplementation as a bio-instructive medium to drive human periosteum-derived cells (hPDCs) toward osteogenic differentiation on three-dimensional (3D) porous Ti6Al4V scaffolds. Through a multilevel factorial analysis, we have systematically investigated the biological effect and interactions of Ca2+ or Pi supplementation in three selected media preparations (i.e., basic growth medium, osteogenic medium [OM], and osteogenic medium without β-glycerophosphate [OM−]) and have identified specific conditions which induce proliferation and significant osteogenic differentiation of two-dimensional (2D) hPDC cultures. These findings were translated from 2D to 3D cultures conditions to instruct hPDCs to populate porous Ti6Al4V scaffolds and to differentiate into the osteoblast lineage with collagenous matrix production and subsequent matrix mineralization on the 3D structures. These osteogenic hybrids may potentially serve as a clinically relevant customizable bone reparative unit, providing a biomimetic template to more effectively mediate in vivo bone regeneration.
Get full access to this article
View all access options for this article.
References
1.
MaroltD., KnezevicM., NovakovicG.V.Bone tissue engineering with human stem cells. Stem Cell Res Ther, 1:1. 2010.
2.
TortelliF., TassoR., LoiaconoF., CanceddaR.The development of tissue-engineered bone of different origin through endochondral and intramembranous ossification following the implantation of mesenchymal stem cells and osteoblasts in a murine model. Biomaterials, 31:242. 2010.
3.
LenasP., MoosM., LuytenF.P.Developmental engineering: a new paradigm for the design and manufacturing of cell-based products. Part I: from three-dimensional cell growth to biomimetics of in vivo development. Tissue Eng Part B Rev, 15:381. 2009.
4.
MargaF., NeaguA., KosztinI., ForgacsG.Developmental biology and tissue engineering. Birth Defects Res C Embryo Today, 81:320. 2007.
5.
van BaelS., KerchkhofsG., MoesenM., KruthJ., SchrootenJ.Morphological and mechanical characterization of Ti6Al4V scaffolds produced with selective laser melting. BartoloP.Eccomas-International Conference on Tissue Engineering, Leiria, Portugal, 2009.
6.
LiJ.P., de WijnJ.R., van BlitterswijkC.A., de GrootK.The effect of scaffold architecture on properties of direct 3D fiber deposition of porous Ti6Al4V for orthopedic implants. J Biomed Mater Res A, 92:33. 2010.
7.
CornetF., AnselmeK., GrardT., RouahiM., NoelB., HardouinP.et al.The influence of culture conditions on extracellular matrix proteins synthesized by osteoblasts derived from rabbit bone marrow. J Biomed Mater Res, 63:400. 2002.
8.
RipamontiU., TsiridisE., FerrettiC., KerawalaC.J., MantalarisA., HeliotisM.Perspectives in regenerative medicine and tissue engineering of bone. Br J Oral Maxillofac Surg, 49:507. 2011.
9.
LenasP., MoosM., LuytenF.P.Developmental engineering: a new paradigm for the design and manufacturing of cell-based products. Part II: from genes to networks: tissue engineering from the viewpoint of systems biology and network science. Tissue Eng Part B Rev, 15:395. 2009.
10.
HutmacherD.W., SittingerM.Periosteal cells in bone tissue engineering. Tissue Eng, 9,Suppl 1:S45. 2003.
11.
RyuY.M., HahY.S., ParkB.W., KimD.R., RohG.S., KimJ.R.et al.Osteogenic differentiation of human periosteal-derived cells in a three-dimensional collagen scaffold. Mol Biol Rep, 38:2887. 2011.
12.
RobertsS.J., GerisL., KerckhofsG., DesmetE., SchrootenJ., LuytenF.P.The combined bone forming capacity of human periosteal derived cells and calcium phosphates. Biomaterials, 32:4393. 2011.
13.
YooJ.U., JohnstoneB.The role of osteochondral progenitor cells in fracture repair. Clin Orthop Relat Res355 Suppl:S73. 1998.
14.
SchimmingR., SchmelzeisenR.Tissue-engineered bone for maxillary sinus augmentation. J Oral Maxillofac Surg, 62:724. 2004.
15.
JaiswalN., HaynesworthS.E., CaplanA.I., BruderS.P.Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem, 64:295. 1997.
16.
HofmannS., KaplanD., Vunjak-NovakovicG., MeinelL.Tissue engineering of bone. Vunjak-NovakovicG., Lan FreshneyR.Culture of Cells for Tissue Engineering. Hoboken, NJ: John Wiley & Sons, Inc., 2006; 323.
17.
ManolagasS.C., SpiessY.H., BurtonD.W., DeftosL.J.Mechanism of action of 1,25-dihydroxyvitamin D3-induced stimulation of alkaline phosphatase in cultured osteoblast-like cells. Mol Cell Endocrinol, 33:27. 1983.
18.
OgstonN., HarrisonA.J., CheungH.F., AshtonB.A., HampsonG.Dexamethasone and retinoic acid differentially regulate growth and differentiation in an immortalised human clonal bone marrow stromal cell line with osteoblastic characteristics. Steroids, 67:895. 2002.
19.
KoshiharaY., HoshiK., OkawaraR., IshibashiH., YamamotoS.Vitamin K stimulates osteoblastogenesis and inhibits osteoclastogenesis in human bone marrow cell culture. J Endocrinol, 176:339. 2003.
20.
PytlikR., StehlikD., SoukupT., KalbacovaM., RypacekF., TrcT.et al.The cultivation of human multipotent mesenchymal stromal cells in clinical grade medium for bone tissue engineering. Biomaterials, 30:3415. 2009.
21.
FrankO., HeimM., JakobM., BarberoA., SchaferD., BendikI.et al.Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro. J Cell Biochem, 85:737. 2002.
22.
RobertsS.J., ChenY., MoesenM., SchrootenJ., LuytenF.P.Enhancement of osteogenic gene expression for the differentiation of human periosteal derived cells. Stem Cell Res, 7:137. 2011.
23.
YuanH., FernandesH., HabibovicP., de BoerJ., BarradasA.M., de RuiterA.et al.Osteoinductive ceramics as a synthetic alternative to autologous bone grafting. Proc Natl Acad Sci USA, 107:13614. 2010.
24.
AnselmeK., NoelB., FlautreB., BlaryM.C., DelecourtC., DescampsM.et al.Association of porous hydroxyapatite and bone marrow cells for bone regeneration. Bone, 25:51S. 1999.
25.
DongJ., UemuraT., ShirasakiY., TateishiT.Promotion of bone formation using highly pure porous beta-TCP combined with bone marrow-derived osteoprogenitor cells. Biomaterials, 23:4493. 2002.
26.
MatsuokaH., AkiyamaH., OkadaY., ItoH., ShigenoC., KonishiJ.et al.In vitro analysis of the stimulation of bone formation by highly bioactive apatite- and wollastonite-containing glass-ceramic: released calcium ions promote osteogenic differentiation in osteoblastic ROS17/2.8 cells. J Biomed Mater Res, 47:176. 1999.
27.
ChaiY.C., RobertsS.J., SchrootenJ., LuytenF.P.Probing the osteoinductive effect of calcium phosphate by using an in-vitro biomimetic model. Tissue Eng Part A, 17:1083. 2011.
28.
NakamuraS., MatsumotoT., SasakiJ., EgusaH., LeeK.Y., NakanoT.et al.Effect of calcium ion concentrations on osteogenic differentiation and hematopoietic stem cell niche-related protein expression in osteoblasts. Tissue Eng Part A, 16:2467. 2010.
29.
McCullenS.D., ZhanJ., OnoratoM.L., BernackiS.H., LoboaE.G.Effect of varied ionic calcium on human adipose-derived stem cell mineralization. Tissue Eng Part A, 16:1971. 2010.
30.
LuZ., ZreiqatH.The osteoconductivity of biomaterials is regulated by bone morphogenetic protein 2 autocrine loop involving alpha2beta1 integrin and mitogen-activated protein kinase/extracellular related kinase signaling pathways. Tissue Eng Part A, 16:3075. 2010.
31.
EyckmansJ., RobertsS.J., SchrootenJ., LuytenF.P.A clinically relevant model of osteoinduction: a process requiring calcium phosphate and BMP/Wnt signalling. J Cell Mol Med, 14:1845. 2010.
32.
LivakK.J., SchmittgenT.D.Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25:402. 2001.
33.
StanfordC.M., JacobsonP.A., EanesE.D., LembkeL.A., MiduraR.J.Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106–01 BSP)J Biol Chem, 270:9420. 1995.
34.
ImpensS., ChenY., MullensS., LuytenF., SchrootenJ.Controlled cell-seeding methodologies: a first step toward clinically relevant bone tissue engineering strategies. Tissue Eng Part C Methods, 16:1575. 2010.
35.
Tullberg-ReinertH., JundtG.In situ measurement of collagen synthesis by human bone cells with a sirius red-based colorimetric microassay: effects of transforming growth factor beta2 and ascorbic acid 2-phosphate. Histochem Cell Biol, 112:271. 1999.
ZhouX., ZhangZ., FengJ.Q., DusevichV.M., SinhaK., ZhangH.et al.Multiple functions of Osterix are required for bone growth and homeostasis in postnatal mice. Proc Natl Acad Sci USA, 107:12919. 2010.
38.
ShibanoK., WatanabeJ., IwamotoM., OgawaR., KanamuraS.Culture of stromal cells derived from medullary cavity of human long bone in the presence of 1,25-dihydroxyvitamin D3, recombinant human bone morphogenetic protein-2, or ipriflavone. Bone, 22:251. 1998.
39.
MadurantakamP.A., RodriguezI.A., CostC.P., ViswanathanR., SimpsonD.G., BeckmanM.J.et al.Multiple factor interactions in biomimetic mineralization of electrospun scaffolds. Biomaterials, 30:5456. 2009.
40.
McCullochC.A., TenenbaumH.C.Dexamethasone induces proliferation and terminal differentiation of osteogenic cells in tissue culture. Anat Rec, 215:397. 1986.
41.
ChoiK.M., SeoY.K., YoonH.H., SongK.Y., KwonS.Y., LeeH.S.et al.Effect of ascorbic acid on bone marrow-derived mesenchymal stem cell proliferation and differentiation. J Biosci Bioeng, 105:586. 2008.
42.
KahlC.R., MeansA.R.Regulation of cell cycle progression by calcium/calmodulin-dependent pathways. Endocr Rev, 24:719. 2003.
43.
EyckmansJ., LuytenF.P.Species specificity of ectopic bone formation using periosteum-derived mesenchymal progenitor cells. Tissue Eng, 12:2203. 2006.
44.
PeterS.J., LiangC.R., KimD.J., WidmerM.S., MikosA.G.Osteoblastic phenotype of rat marrow stromal cells cultured in the presence of dexamethasone, beta-glycerolphosphate, and L-ascorbic acid. J Cell Biochem, 71:55. 1998.
45.
MendesS.C., TibbeJ.M., VeenhofM., BothS., OnerF.C., van BlitterswijkC.A.et al.Relation between in vitro and in vivo osteogenic potential of cultured human bone marrow stromal cells. J Mater Sci Mater Med, 15:1123. 2004.
46.
ChangY.L., StanfordC.M., KellerJ.C.Calcium and phosphate supplementation promotes bone cell mineralization: implications for hydroxyapatite (HA)-enhanced bone formation. J Biomed Mater Res, 52:270. 2000.
47.
SchoetersG.E., de Saint-GeorgesL., Van den HeuvelR., VanderborghtO.Mineralization of adult mouse bone marrow in vitro. Cell Tissue Kinet, 21:363. 1988.
48.
KassemM., RisteliL., MosekildeL., MelsenF., EriksenE.F.Formation of osteoblast-like cells from human mononuclear bone marrow cultures. APMIS, 99:269. 1991.
49.
TenenbaumH.C.Role of organic phosphate in mineralization of bone in vitro. J Dent Res 60Spec No C:1586–91981.
50.
LuriiaE.A., OwenM., FridenshteinA., KuznetsovS.A., GenkinaE.N.[Bone formation in bone marrow organ cultures]Biull Eksp Biol Med, 101:481. 1986.
51.
MuradS., GroveD., LindbergK.A., ReynoldsG., SivarajahA., PinnellS.R.Regulation of collagen synthesis by ascorbic acid. Proc Natl Acad Sci USA, 78:2879. 1981.
52.
FernandesH., MentinkA., BankR., StoopR., van BlitterswijkC., de BoerJ.Endogenous collagen influences differentiation of human multipotent mesenchymal stromal cells. Tissue Eng Part A, 16:1693. 2010.
53.
De BariC., Dell'AccioF., KarystinouA., GuillotP.V., FiskN.M., JonesE.A.et al.A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells. Arthritis Rheum, 58:240. 2008.
54.
KaartinenM.T., PirhonenA., Linnala-KankkunenA., MaenpaaP.H.Transglutaminase-catalyzed cross-linking of osteopontin is inhibited by osteocalcin. J Biol Chem, 272:22736. 1997.
55.
FujitaT., IzumoN., FukuyamaR., MeguroT., NakamutaH., KohnoT.et al.Phosphate provides an extracellular signal that drives nuclear export of Runx2/Cbfa1 in bone cells. Biochem Biophys Res Commun, 280:348. 2001.
56.
KomoriT.Regulation of osteoblast differentiation by runx2. Adv Exp Med Biol, 658:43. 2010.
57.
WojtowiczA.M., TemplemanK.L., HutmacherD.W., GuldbergR.E., GarciaA.J.Runx2 overexpression in bone marrow stromal cells accelerates bone formation in critical-sized femoral defects. Tissue Eng Part A, 16:2795. 2010.
58.
YuY.Y., LieuS., LuC., ColnotC.Bone morphogenetic protein 2 stimulates endochondral ossification by regulating periosteal cell fate during bone repair. Bone, 47:65. 2010.
59.
KaleS., BiermannS., EdwardsC., TarnowskiC., MorrisM., LongM.W.Three-dimensional cellular development is essential for ex vivo formation of human bone. Nat Biotechnol, 18:954. 2000.
60.
GrueneM., DeiwickA., KochL., SchlieS., UngerC., HofmannN.et al.Laser printing of stem cells for biofabrication of scaffold-free autologous grafts. Tissue Eng Part C Methods, 17:79. 2011.
61.
TaiG., PolakJ.M., BishopA.E., ChristodoulouI., ButteryL.D.Differentiation of osteoblasts from murine embryonic stem cells by overexpression of the transcriptional factor osterix. Tissue Eng, 10:1456. 2004.
62.
JarrahyR., HuangW., RudkinG.H., LeeJ.M., IshidaK., BerryM.D.et al.Osteogenic differentiation is inhibited and angiogenic expression is enhanced in MC3T3-E1 cells cultured on three-dimensional scaffolds. Am J Physiol Cell Physiol, 289:C408. 2005.
63.
O'NeillW.C.Pyrophosphate, alkaline phosphatase, and vascular calcification. Circ Res, 99:e2. 2006.
64.
LandisW.J., SilverF.H., FreemanJ.W.Collagen as a scaffold for biomimetic mineralization of vertebrate tissues. J Mater Chem, 16:1495. 2006.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
